These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 10767974
1. Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experience. Uderzo C, Biagi E, Rovelli A, Balduzzi A, Schirò R, Longoni D, Arrigo C, Nicolini B, Placa L, Da Prada A, Mascaretti L, Giltri G, Galimberti S, Valsecchi MG, Locasciulli A, Masera G. Pediatr Med Chir; 2000; 21(4):157-63. PubMed ID: 10767974 [Abstract] [Full Text] [Related]
2. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
3. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Kaya Z, Weiner DJ, Yilmaz D, Rowan J, Goyal RK. Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213 [Abstract] [Full Text] [Related]
4. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D. Klin Padiatr; 2004 Jul; 216(6):356-63. PubMed ID: 15565551 [Abstract] [Full Text] [Related]
9. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM. Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502 [Abstract] [Full Text] [Related]
10. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON). Bone Marrow Transplant; 2002 Jul 17; 30(1):9-13. PubMed ID: 12105771 [Abstract] [Full Text] [Related]
11. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb 17; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related]
12. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D. Klin Padiatr; 2005 Feb 17; 217(3):135-41. PubMed ID: 15858704 [Abstract] [Full Text] [Related]
13. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Tauchmanovà L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A. Cancer; 2002 Sep 01; 95(5):1076-84. PubMed ID: 12209694 [Abstract] [Full Text] [Related]
14. Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Yumura-Yagi K, Inoue M, Sakata N, Okamura T, Yasui M, Sawada A, Sato E, Chayama K, Endo C, Sasabe M, Miyamura T, Park YD, Nakano T, Inagaki J, Kishimoto T, Nomura K, Saito I, Hamada S, Nakano T, Hashii Y, Kawa K. Bone Marrow Transplant; 2005 Aug 01; 36(4):307-13. PubMed ID: 15968285 [Abstract] [Full Text] [Related]
15. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR. Bone Marrow Transplant; 2000 Oct 01; 26(7):711-6. PubMed ID: 11042650 [Abstract] [Full Text] [Related]
17. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis. Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R, Gadner H, Peters C. Bone Marrow Transplant; 1999 May 01; 23(10):1049-53. PubMed ID: 10373072 [Abstract] [Full Text] [Related]
19. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan 01; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
20. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Jacobe SJ, Hassan A, Veys P, Mok Q. Crit Care Med; 2003 May 01; 31(5):1299-305. PubMed ID: 12771594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]